乳胶凝集试验检测套组市场 - 全球产业规模、份额、趋势、机会及预测（按产品类型、测试类型、样品类型、最终用户、地区和竞争格局划分，2021-2031年）

全球乳胶凝集测试检测套组市场预计将从 2025 年的 6.3254 亿美元成长到 2031 年的 8.4091 亿美元，复合年增长率为 4.86%。

这些诊断工具利用包覆特定抗体或抗原的乳胶微粒，透过可见的凝集反应来辨识生物样本中的目标病原体。该市场的成长主要受脑膜炎和金黄色葡萄球菌等感染疾病在全球范围内日益普遍的推动，从而在临床和照护现场环境中催生了对快速、经济的筛检方法的需求。这些基本驱动因素独立于更广泛的技术变革，旨在满足检测设施有限地区对便利诊断方案的迫切需求。

然而，市场面临许多挑战：日益复杂的法规环境要求製造商投入大量资金。欧洲医疗技术展（MedTech Europe）的数据显示，到2024年，79%的体外诊断医疗设备製造商将至少部分产品系列转型以符合新的体外诊断医疗设备法规（IVD法规），而这需要耗费大量的营运资源和时间才能实现合规。日益沉重的监管负担正在造成产品核可瓶颈，限制了新型诊断解决方案的推出，并最终阻碍了其在全球范围内更广泛的市场准入。

市场驱动因素

感染疾病日益流行是全球乳胶凝集检测套组市场的主要驱动因素，推动了对梅毒螺旋体和金黄色葡萄球菌等病原体进行高效筛检的需求。这些试剂盒因其能够快速提供定性和半定量结果而备受青睐，使其成为临床环境中疫情管理和感染预防的关键工具。例如，美国疾病管制与预防中心 (CDC) 于 2025 年 9 月发布的初步监测数据显示，2024 年美国报告了近 4000 例先天性梅毒病例，凸显了有效产前筛检的重要性。此外，医院感染也持续推动市场需求。根据英国政府 2025 年 10 月的报告，2025 年第一季每 10 万人中有 1.8 例抗药性金黄色葡萄球菌(MRSA) 菌血症发生，这支持了继续依赖凝集试验进行细菌确诊。

除了临床必要性之外，乳胶凝集试验的成本效益和快速出结果的优势也巩固了其市场地位，尤其是在资源匮乏、缺乏先进分子诊断基础设施或相关设施成本过高的地区。这些试验无需复杂设备，操作流程简便，因此适用于照护现场诊断和常规检查室应用。这种经济优势确保了其在数位技术兴起的背景下仍能维持商业性可行性。例如，Bio-Rad Laboratories 于 2025 年 2 月报告称，其临床诊断部门 2024 财年全年净销售额达 15.379 亿美元。这项业绩主要得益于全球对核心诊断和分型产品的持续需求。这种财务韧性表明，经济实惠、快速的诊断解决方案仍然是现代医疗保健的重要组成部分，从而保证了乳胶凝集试剂盒的稳定采购量。

市场挑战

体外诊断领域严格的监管架构对全球乳胶凝集试验检测套组市场的成长构成重大障碍。製造商面临日益增长的合规成本和漫长的审批週期，迫使他们将资金从创新和市场扩张方面转移出去。这种环境导致产品核可出现严重瓶颈，使企业难以及时推出新型或改良的乳胶凝集试验产品。因此，製造商越来越不愿意优先选择监管要求复杂的市场进行产品推出，担心漫长的审批週期会导致竞争优势丧失和产生收入延迟。

这种监管压力正对新型诊断解决方案的供应产生直接的负面影响。根据欧洲医疗技术协会（MedTech Europe）预测，到2025年，这些监管限制将导致欧盟作为主要製造商推出新型诊断设备首选地区的比例下降40%。这一趋势凸显了新诊断产品上市数量的直接减少。监管负担的加重抑制了新检测方法的发布，限制了市场提供现代化、经济高效的感染疾病筛检工具的能力，进而减缓了整体收入成长，并限制了全球市场获得所需诊断能力的途径。

市场趋势

乳胶凝集测试试验的应用范围从临床诊断扩展到工业病原体监测，代表着一种改变市场的趋势。这项转变的驱动力在于迫切需要在整个农业供应链中检测食源性病原体，例如沙门氏菌和大肠桿菌。快速、经济高效的筛检对于预防污染至关重要。大规模集体爆发的频繁发生，需要即时采取控制措施，避免复杂培养方法带来的延误，这进一步增加了对这些多功能检测解决方案的需求。例如，2025年8月，美国疾病管制与预防中心（CDC）报告了一起与受污染鸡蛋相关的多州沙门氏菌肠炎集体爆发，感染了14个州的105人，凸显了食品加工和通路中快速检测工具的迫切需求。

同时，随着领先製造商寻求拓展诊断产品组合和市场覆盖范围，策略性产业重组和联盟正在改变竞争格局。各公司越来越多地利用合作来整合互补技术，并在高需求地区巩固市场地位，从而在持续的监管阻力下优化收入来源。这种方法使公司能够在充满挑战的经济环境下，共用资源进行创新，同时保持财务韧性。 2025年7月，赛默飞世尔科技宣布第二季销售额达108.5亿美元，并明确将强劲的业绩归功于营运效率的提升和策略伙伴关係关係的拓展，例如与赛诺菲的合作。这一趋势表明，主要企业正依靠协同合作来维持其在全球诊断领域的成长和创新。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球乳胶凝集检测套组市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品类型（酵素连结免疫吸附试验、间接萤光、血凝抑制试验、血清中及试验）
  • 依检测类型（抗体检测、抗原检测）
  • 检体类型（血液、尿液、脑脊髓液、其他）
  • 依最终用户（医院药局、零售药局、网路药局）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美乳胶凝集检测套组市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲乳胶凝集检测套组市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区乳胶凝集试验检测套组市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲乳胶凝集试验检测套组市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲乳胶凝集检测套组市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球乳胶凝集试验检测套组市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Thermo Fisher Scientific, Inc.
• Biomerieux SA
• Biolegend, Inc.
• Eurofins Scientific
• Hardy Diagnostics
• Himedia Laboratories
• Biotec
• Creative Diagnostics
• ELITechGroup
• ARKRAY, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Latex Agglutination Test Kits Market is projected to expand from USD 632.54 Million in 2025 to USD 840.91 Million by 2031, achieving a CAGR of 4.86%. These diagnostic tools function by utilizing latex microparticles coated with specific antibodies or antigens to identify target pathogens in biological samples via a visible clumping reaction. The market is primarily underpinned by the growing global prevalence of infectious diseases, such as meningitis and Staphylococcus aureus, which creates a demand for rapid and affordable screening methods in both clinical and point-of-care environments. These fundamental drivers operate independently of broader technological shifts, addressing the critical and immediate need for accessible diagnostic options in areas with limited laboratory infrastructure.

However, the market faces a substantial obstacle in the form of an increasingly intricate regulatory environment that necessitates significant investment from manufacturers. Data from MedTech Europe indicates that in 2024, 79% of In Vitro Diagnostic manufacturers had shifted at least a portion of their product portfolios to comply with the new IVD Regulation, highlighting the considerable operational resources and time required for compliance. This elevated regulatory burden creates bottlenecks for product approvals and restricts the introduction of new diagnostic solutions, thereby impeding broader entry into the global market.

Market Driver

The increasing prevalence of infectious diseases serves as a primary catalyst for the Global Latex Agglutination Test Kits Market, driving the need for robust screening capabilities for pathogens such as Treponema pallidum and Staphylococcus aureus. These kits are preferred for their ability to deliver quick qualitative and semi-quantitative results, which are essential for managing outbreaks and preventing transmission in clinical settings. Highlighting this urgency, provisional surveillance data released by the Centers for Disease Control and Prevention in September 2025 indicated that nearly 4,000 cases of congenital syphilis were reported in the United States during 2024, emphasizing the critical need for effective prenatal screening. Furthermore, hospital-acquired infections continue to drive demand; the UK Government reported in October 2025 that 1.8 out of every 100,000 individuals developed Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in the first quarter of 2025, reinforcing the continued reliance on agglutination tests for bacterial confirmation.

In addition to clinical necessity, cost-efficiency and rapid turnaround times strengthen the market position of latex agglutination assays, particularly in resource-limited regions where advanced molecular infrastructure is unavailable or too expensive. These tests offer a simplified workflow that does not require complex instrumentation, making them suitable for point-of-care diagnostics and routine laboratory use. This economic advantage ensures their sustained commercial relevance even as digital technologies emerge. For instance, Bio-Rad Laboratories reported in February 2025 that its Clinical Diagnostics segment achieved $1,537.9 million in full-year net sales for 2024, a performance driven largely by the enduring global demand for core diagnostic and typing products. This financial resilience demonstrates that affordable, rapid diagnostic solutions remain a foundational element of modern healthcare, securing consistent procurement volumes for latex-based kits.

Market Challenge

The rigorous regulatory framework governing in vitro diagnostics constitutes a significant barrier to the growth of the Global Latex Agglutination Test Kits Market. Manufacturers are confronting rising compliance costs and extended certification timelines, which compel a strategic diversion of capital away from innovation and market expansion efforts. This environment creates a major bottleneck for product approvals, making it challenging for companies to introduce new or enhanced latex agglutination assays in a timely fashion. Consequently, manufacturers are increasingly reluctant to prioritize markets with complex regulatory requirements for their initial product launches, fearing prolonged delays that could erode competitive advantages and postpone revenue generation.

This regulatory pressure directly negatively impacts the availability of new diagnostic solutions. According to MedTech Europe, the selection of the European Union as the first launch geography for new diagnostic devices declined by 40% among large manufacturers in 2025 due to these regulatory constraints. This trend highlights a direct contraction in the introduction of fresh diagnostic products. By disincentivizing the release of new assays, the heightened regulatory burden limits the market's capacity to offer updated, cost-effective screening tools for infectious diseases, thereby slowing the overall revenue trajectory and restricting the entry of necessary diagnostic capabilities into the global market.

Market Trends

The expansion into food safety and water quality testing marks a transformative trend for the market, extending the application of latex agglutination assays beyond clinical diagnostics into industrial pathogen monitoring. This shift is driven by the critical necessity to detect foodborne pathogens such as Salmonella and E. coli across agricultural supply chains, where rapid and cost-effective screening is essential to prevent contamination. The demand for these versatile testing solutions is amplified by frequent large-scale outbreaks that require immediate containment measures without the delays associated with complex culture methods. For example, the Centers for Disease Control and Prevention reported in August 2025 that a multistate outbreak of Salmonella Enteritidis linked to contaminated eggs infected 105 individuals across 14 states, highlighting the urgent requirement for deployed rapid detection tools in food processing and distribution channels.

Simultaneously, strategic industry consolidations and partnerships are reshaping the competitive landscape as major manufacturers seek to broaden their diagnostic portfolios and operational reach. Companies are increasingly leveraging collaborations to integrate complementary technologies and secure market presence in high-demand regions, thereby optimizing revenue streams despite ongoing regulatory headwinds. This approach allows firms to pool resources for innovation while maintaining financial resilience in a challenging economic environment. In July 2025, Thermo Fisher Scientific reported second-quarter revenue of $10.85 billion, explicitly attributing its robust performance to operational efficiencies and the expansion of strategic partnerships, such as its collaboration with Sanofi. This trend indicates that leading firms are relying on synergistic alliances to sustain growth and innovation within the global diagnostics sector.

Key Market Players

• Thermo Fisher Scientific, Inc.
• Biomerieux SA
• Biolegend, Inc.
• Eurofins Scientific
• Hardy Diagnostics
• Himedia Laboratories
• Biotec
• Creative Diagnostics
• ELITechGroup
• ARKRAY, Inc.

Report Scope

In this report, the Global Latex Agglutination Test Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Latex Agglutination Test Kits Market, By Product Type

• ELISA
• Indirect Fluorescent
• Hemagglutination Inhibition
• Serum Neutralization

Latex Agglutination Test Kits Market, By Test Type

• Antibody Detection
• Antigen Testing

Latex Agglutination Test Kits Market, By Sample Type

• Blood
• Urine
• Cerebrospinal Fluid
• Others

Latex Agglutination Test Kits Market, By End User

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Latex Agglutination Test Kits Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Latex Agglutination Test Kits Market.

Available Customizations:

Global Latex Agglutination Test Kits Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Latex Agglutination Test Kits Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (ELISA, Indirect Fluorescent, Hemagglutination Inhibition, Serum Neutralization)
  • 5.2.2. By Test Type (Antibody Detection, Antigen Testing)
  • 5.2.3. By Sample Type (Blood, Urine, Cerebrospinal Fluid, Others)
  • 5.2.4. By End User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Latex Agglutination Test Kits Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Test Type
  • 6.2.3. By Sample Type
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Latex Agglutination Test Kits Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Test Type
      • 6.3.1.2.3. By Sample Type
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Latex Agglutination Test Kits Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Test Type
      • 6.3.2.2.3. By Sample Type
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Latex Agglutination Test Kits Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Test Type
      • 6.3.3.2.3. By Sample Type
      • 6.3.3.2.4. By End User

7. Europe Latex Agglutination Test Kits Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Test Type
  • 7.2.3. By Sample Type
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Latex Agglutination Test Kits Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Test Type
      • 7.3.1.2.3. By Sample Type
      • 7.3.1.2.4. By End User
  • 7.3.2. France Latex Agglutination Test Kits Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Test Type
      • 7.3.2.2.3. By Sample Type
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Latex Agglutination Test Kits Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Test Type
      • 7.3.3.2.3. By Sample Type
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Latex Agglutination Test Kits Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Test Type
      • 7.3.4.2.3. By Sample Type
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Latex Agglutination Test Kits Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Test Type
      • 7.3.5.2.3. By Sample Type
      • 7.3.5.2.4. By End User

8. Asia Pacific Latex Agglutination Test Kits Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Test Type
  • 8.2.3. By Sample Type
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Latex Agglutination Test Kits Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Test Type
      • 8.3.1.2.3. By Sample Type
      • 8.3.1.2.4. By End User
  • 8.3.2. India Latex Agglutination Test Kits Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Test Type
      • 8.3.2.2.3. By Sample Type
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Latex Agglutination Test Kits Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Test Type
      • 8.3.3.2.3. By Sample Type
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Latex Agglutination Test Kits Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Test Type
      • 8.3.4.2.3. By Sample Type
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Latex Agglutination Test Kits Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Test Type
      • 8.3.5.2.3. By Sample Type
      • 8.3.5.2.4. By End User

9. Middle East & Africa Latex Agglutination Test Kits Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Test Type
  • 9.2.3. By Sample Type
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Latex Agglutination Test Kits Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Test Type
      • 9.3.1.2.3. By Sample Type
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Latex Agglutination Test Kits Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Test Type
      • 9.3.2.2.3. By Sample Type
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Latex Agglutination Test Kits Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Test Type
      • 9.3.3.2.3. By Sample Type
      • 9.3.3.2.4. By End User

10. South America Latex Agglutination Test Kits Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Test Type
  • 10.2.3. By Sample Type
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Latex Agglutination Test Kits Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Test Type
      • 10.3.1.2.3. By Sample Type
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Latex Agglutination Test Kits Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Test Type
      • 10.3.2.2.3. By Sample Type
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Latex Agglutination Test Kits Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Test Type
      • 10.3.3.2.3. By Sample Type
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Latex Agglutination Test Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Biomerieux SA
• 15.3. Biolegend, Inc.
• 15.4. Eurofins Scientific
• 15.5. Hardy Diagnostics
• 15.6. Himedia Laboratories
• 15.7. Biotec
• 15.8. Creative Diagnostics
• 15.9. ELITechGroup
• 15.10. ARKRAY, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer